True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

NIO stock looks oversold vs business progress. Q3 2025 shows operating leverage, margin/mix gains and cost discipline guiding ...

The prevalence of legacy systems and delayed patching processes create critical vulnerabilities in industrial environments.

Discover the concept of price leadership, its impact on market pricing, and explore the three primary types: barometric, ...